140 related articles for article (PubMed ID: 16143515)
1. Pharmaceutical industry, investigators and institutions: Partners or tools?
Verweij J
Eur J Cancer; 2005 Oct; 41(15):2204-5. PubMed ID: 16143515
[No Abstract] [Full Text] [Related]
2. The difficulties industry is facing with investigators.
Blackledge GR
Eur J Cancer; 2005 Oct; 41(15):2210-2. PubMed ID: 16214043
[TBL] [Abstract][Full Text] [Related]
3. Small study on industry trial sponsorship leads to big questions about quality and bias.
Twombly R
J Natl Cancer Inst; 2007 Jul; 99(13):988-90. PubMed ID: 17596566
[No Abstract] [Full Text] [Related]
4. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
Peppercorn J; Blood E; Winer E; Partridge A
Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054
[TBL] [Abstract][Full Text] [Related]
5. [Public health and chemical-pharmaceutical companies].
Ribeiro MA
Hist Cienc Saude Manguinhos; 2000 Nov-2001 Feb; 7(3):607-26. PubMed ID: 16683337
[TBL] [Abstract][Full Text] [Related]
6. Approaches vary for clinical trials in developing countries.
Hayasaka E
J Natl Cancer Inst; 2005 Oct; 97(19):1401-3. PubMed ID: 16204687
[No Abstract] [Full Text] [Related]
7. Wanted: social entrepreneurs.
Nature; 2005 Apr; 434(7036):941. PubMed ID: 15846306
[No Abstract] [Full Text] [Related]
8. Professional development of statisticians in the pharmaceutical sector: evolution over the past decade and into the future.
Lewis T
Pharm Stat; 2008; 7(3):158-69. PubMed ID: 18720452
[TBL] [Abstract][Full Text] [Related]
9. Drug development research: diabetes favored over cardiovascular disease?
Suckling K
Curr Opin Investig Drugs; 2009 Mar; 10(3):217-9. PubMed ID: 19333877
[No Abstract] [Full Text] [Related]
10. Life beyond synthesis.
Russo E
Nature; 2003 Jul; 424(6948):594-6. PubMed ID: 12891371
[No Abstract] [Full Text] [Related]
11. Success in an uneven market.
Russo E
Nature; 2003 Jul; 424(6948):597. PubMed ID: 12891372
[No Abstract] [Full Text] [Related]
12. A demanding world.
Smaglik P
Nature; 2003 Jul; 424(6944):109. PubMed ID: 12840765
[No Abstract] [Full Text] [Related]
13. Paging all doctors.
Ready T
Nat Med; 2007 Jun; 13(6):658-9. PubMed ID: 17554324
[No Abstract] [Full Text] [Related]
14. Stimulating pharmaceutical innovation in the EU.
Annemans L; Cleemput I; Hulstaert F; Simoens S
Expert Rev Pharmacoecon Outcomes Res; 2011 Jun; 11(3):235-9. PubMed ID: 21671690
[No Abstract] [Full Text] [Related]
15. Where is the optimism? Warrior teachings to regain the drug discovery spirit.
Uitdehaag JC
Drug Discov Today; 2007 Feb; 12(3-4):105-7. PubMed ID: 17275729
[No Abstract] [Full Text] [Related]
16. A clinical trial in a developing country: many questions, few answers.
Kietinun S; Gupte MD; Sengupta A
Issues Med Ethics; 2003; 11(3):89-90. PubMed ID: 16335511
[No Abstract] [Full Text] [Related]
17. Racial disparities among clinical research investigators.
Getz K; Faden L
Am J Ther; 2008; 15(1):3-11. PubMed ID: 18223347
[TBL] [Abstract][Full Text] [Related]
18. Bioethics. Researchers attack newspaper probe of trials.
Kaiser J
Science; 2006 Sep; 313(5794):1714. PubMed ID: 16990521
[No Abstract] [Full Text] [Related]
19. Present at the creation.
Engleman R
Group Pract; 1975; 24(4):8-11, 26. PubMed ID: 10297162
[No Abstract] [Full Text] [Related]
20. Science, medicine and... the markets.
Pawlotsky JM
J Hepatol; 2006 Sep; 45(3):341-2. PubMed ID: 16854496
[No Abstract] [Full Text] [Related]
[Next] [New Search]
